May And Baker Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 2006.
2006 Delhi, Delhi, India Active
Last Updated:
Access Report
About May And Baker Pharmaceuticals Limited

May And Baker Pharmaceuticals Limited, a active public limited company, was established on 23 January 2006 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U15400DL2006PLC145272. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Employing 8 professional, Its leadership includes Manju Bist (Director), Pooja Sharma (Director), Ritu Mirg (Director). Past directors included Allen Dass, Kusum Pal Sharma, Manju Bist. It holds no open charges and ₹10.00 Cr settled loans. Its latest AGM occurred on 11 May 2025, with the balance sheet filed on 31 March 2025. It is based at 301, 3Rd Floor, Laxmi Tower Lsc, Block- C, Saraswati Vihar, Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15400DL2006PLC145272

  • Registration Number

    145272

  • Incorporation Date

    23 January 2006

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 20 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 10.00 Cr
  • Revenue Growth **** 6.20%
  • Profit Growth **** -183.53%
  • Ebitda **** 15.83%
  • Net Worth -16.00%
  • Total Assets **** 26.91%
Company report

May And Baker Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into May And Baker Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at May And Baker Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Manju Bist Director 02 Mar 2009 Current
Pooja Sharma Director 15 May 2015 Current
Ritu Mirg Director 02 Mar 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 13 May 2015 Past
Pramod Abcsdd Additional Director 02 Mar 2009 Past
Pramod Abcsdd Additional Director 11 Jul 2016 Past
Pramod Abcsdd Additional Director 18 Mar 2008 Past
Pramod Abcsdd Whole-Time Director 22 Dec 2020 Past
Pramod Abcsdd Additional Director 28 Apr 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of May And Baker Pharmaceuticals.

May And Baker Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.2% increase. The company also saw a substantial fall in profitability, with a 183.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16%.

May And Baker Pharmaceuticals revenue growth over time
May And Baker Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 6.20%
*******
*******
*******
*******
Revenue from Operations
*******
 7.13%
*******
*******
*******
*******
Total Assets
*******
 26.91%
*******
*******
*******
*******
Profit or Loss
*******
 -183.53%
*******
*******
*******
*******
Net Worth
*******
 -16.00%
*******
*******
*******
*******
EBITDA
*******
 15.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of May And Baker Pharmaceuticals?

In 2023, May And Baker Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹100,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 5.00 Cr
  • Yes Bank Limited : 5.00 Cr
Latest Charge Details
Date Lender Amount Status
22 Jun 2023 Hdfc Bank Limited ₹5.00 Cr Satisfied
19 May 2017 Yes Bank Limited ₹5.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at May And Baker Pharmaceuticals?

May And Baker Pharmaceuticals has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of May And Baker Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped May And Baker Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on May And Baker Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on May And Baker Pharmaceuticals Limited last Annual general meeting of members was held on 11 May 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity May And Baker Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Charges

    The activity A charge registered on 19 May 2017 via Charge ID 100101977 with Yes Bank Limited was fully satisfied on 15 Apr 2024. was completed.

  • Charges

    Progress on A charge registered on 22 Jun 2023 via Charge ID 100743628 with Hdfc Bank Limited was fully satisfied on 12 Jan 2024. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 50.00 M with Charge ID 100743628 was registered on 22 Jun 2023. was recorded as a recent event.

  • Charges

    A charge with Yes Bank Limited amounted to Rs. 50.00 M with Charge ID 100101977 was registered on 19 May 2017. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of May And Baker Pharmaceuticals Limited?

The CIN of May And Baker Pharmaceuticals Limited is U15400DL2006PLC145272.

Where is May And Baker Pharmaceuticals Limited headquartered?

May And Baker Pharmaceuticals Limited is headquartered at 301, 3Rd Floor, Laxmi Tower Lsc, Block- C, Saraswati Vihar, Delhi, Delhi, 110034.

When was May And Baker Pharmaceuticals Limited incorporated?

May And Baker Pharmaceuticals Limited was incorporated on 23 January 2006.

Who are the current directors of May And Baker Pharmaceuticals Limited?

The current directors of May And Baker Pharmaceuticals Limited are

What is the primary industry of May And Baker Pharmaceuticals Limited?

The primary industry of May And Baker Pharmaceuticals Limited is Hospital And Medical Care.

Is May And Baker Pharmaceuticals Limited a listed company?

May And Baker Pharmaceuticals Limited is unlisted.

What is the capital structure of May And Baker Pharmaceuticals Limited?

The authorized capital of May And Baker Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of May And Baker Pharmaceuticals Limited?

The compliance status of May And Baker Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available